Their orthotopic syngeneic glioma model demonstrated that IDH1 R132H mutation suppressed the STAT1 protein expression via 2-HG, thus decreasing the type 1-associated chemokines such as CXCL10 and affecting CD8+ T cell aggregation (13) (Figure 2). This evidence concerns the gene IDH1 and central nervous system cancer.